As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger ...
Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...